Engage with senior-level clinical quality and operations professionals at the 7th Proactive GCP Compliance conference on March 14-16 in Philadelphia, and learn how to effectively build quality risk management approaches into your clinical operations to optimize research, maintain GCP compliance, contain costs and ensure patient safety.
Christine Block, Executive Director, QA-GCP, INCYTE CORPORATION
Sandra Harrison, Senior Manager, Clinical Records & Information Management (CRIM), TEVA PHARMACEUTICALS
Michele Weitz, Director, GCP Compliance Operations, CLOVIS ONCOLOGY, INC.
Celeste M. Gonzalez, B.S., CVT, RQAP-GCP, CCRP, Principal Specialist, Clinical Quality Assurance, BOSTON SCIENTIFIC
Jennifer LaLonde, RN, BSN, CCRC, Director of Research, CARDIAC & VASCULAR RESEARCH CENTER OF NORTHERN MICHIGAN
This conference is designed for professionals from pharmaceutical, biotechnology and medical device companies with responsibilities in the following areas:
“One of the most vibrant and interactive conferences I have attended — it was most impressive and I am keen to attend next year!” —Nicky Dodsworth, VP Global Quality Assurance, PREMIER RESEARCH
“This is one of the few conferences that continually provides focused discussions amongst a diverse group. Once again I’ve gained many takeaways that my team will look at implementing.” —Doreen McGirl, Associate Director, Clinical Quality Management, OTSUKA
“Attendees are mostly high-level resulting in valuable discussions on advanced processes and advanced solutions.” —Katie D. Alberta, BSN, Global Head, CQA; GCP & GPvP, ALKERMES, INC.
“Great forum to meet your peers, exchange ideas and share successes.” —Steve Bliss, Business Development, ADAMAS
Great learning and networking opportunity.” —Elias Querales, QA Manager, SEAVIEW RESEARCH, INC.
“Wonderful to hear the same themes and concerns cross industry as the research world moves to a more remote risk-based monitoring approach.” —Caitlin Beatty, Manager, Quality Monitoring & Compliance, JANSSEN